TRVI
Trevi Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -15.8% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 67.23M | $1.24B | +8 | −8 |
| Q1 2026 | 77 | +2 | 59.43M | $710.63M | +8 | −6 |
| Q4 2025 | 75 | 0 | 58.45M | $731.74M | +1 | −1 |
| Q3 2025 | 18 | 0 | 44.17M | $404.20M | — | — |
| Q2 2025 | 15 | 0 | 25.58M | $139.93M | +1 | −1 |
| Q1 2025 | 12 | 0 | 12.85M | $80.81M | +1 | −1 |
| Q4 2024 | 12 | +4 | 15.26M | $62.88M | +4 | — |
| Q3 2024 | 7 | +3 | 5.91M | $19.73M | +3 | — |
| Q2 2024 | 4 | — | 5.62M | $16.74M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 3.23M | -26.6% | $20.30M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Marshall Wace ✦ | 2.55M | +5851.0% | $16.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Marshall Wace ✦ | 2.55M | +5851.0% | $16.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 2.55M | +5851.0% | $16.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 2.37M | -42.9% | $14.89M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 1.61M | +24.3% | $10.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 1.61M | +24.3% | $10.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passiv) | 1.42M | +21.7% | $8.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 823.25K | +356.3% | $5.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 440.00K | -82.4% | $2.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 127.45K | Neu | $801,673 | 0.0% | New | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 127.45K | Neu | $801,673 | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 117.74K | -13.3% | $740,559 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 88.90K | -11.4% | $559,181 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 32.16K | +27.8% | $203,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 27.72K | +20.4% | $174,359 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 27.72K | +20.4% | $174,359 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 27.72K | +20.4% | $174,359 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Wellington Management | $801,673 | 0.0% |
| Wellington Management | $801,673 | 0.0% |
Ausgestiegen
| Citadel Advisors | $5.08M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 198 Inhaber, 134.86M Anteile, $1.61B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.